Medical Condition

pancreatic neoplasms

Total Trials

9

Recruiting Now

9

Trial Phases

Phase 2, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for pancreatic neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pancreatic neoplasms Clinical Trials

How many clinical trials are currently recruiting for pancreatic neoplasms?

ClinicalMetric currently tracks 9 actively recruiting clinical trials for pancreatic neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for pancreatic neoplasms?

pancreatic neoplasms research spans Phase 1 (2 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a pancreatic neoplasms clinical trial?

Eligibility criteria for pancreatic neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1 trial

Minia University 1 trial

University Hospital, Montpellier 1 trial

Nuvance Health 1 trial

Karolinska University Hospital 1 trial

Recruiting Clinical Trials

NCT06532617 Phase 2

Recruiting

Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer

Shanghai General Hospital, Sha...

View Trial →

NCT07139236

Recruiting

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology

University Hospital, Montpelli...

View Trial →

NCT04406831

Recruiting

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Karolinska University Hospital

View Trial →

NCT07605819

Recruiting

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

Institut Paoli-Calmettes Pancreatic Neoplasms Database

Institut Paoli-Calmettes

View Trial →

NCT05944237 Phase 1, Phase 2

Recruiting

HTL0039732 in Participants With Advanced Solid Tumours

Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms

Chia Tai Tianqing Pharmaceutic...

View Trial →

Related Conditions

stomach neoplasms (2) pancreatic fistula (1) pancreatic cancer stage iii (1) pancreatic cancer stage iv (1) pancreatic ductal adenocarcinoma (1) bile duct neoplasms (1) epithelial ovarian cancer (1) pancreatic cancer (1) neoplasms (1) prostatic neoplasms castration resistant (1) esophageal neoplasms (1) head and neck neoplasms (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology